the injection may have triggered a reaction far more lethal than any future distant threat of a comparatively rare disease".
The Health Editor of The Times, alongside sound advice under the headline "There are always risks, but this vaccine will save lives", strongly implied that HPV vaccine had caused Natalie's death. "Most experts agree that vaccinating against the virus that causes cervical cancer is a good thing," he wrote. "It carries risks, as fatally shown in Coventry, but these are outweighed by benefits. Getting this across is far from easy. An unknown life saved decades down the line does not capture the imagination like the spectre on a young life lost."
Equally surprising was an article in The Daily Telegraph (30 September) by a researcher at the Wellcome Trust Centre for the History of Medicine, London. "Politicians have long known that a life lost today is far more emotive than a life saved in some hard-to-glimpse future," Mark Honigsbaum wrote. "Never mind that history is pitted with examples of vaccines that the public was falsely assured were safe: the experts reason that in every mass vaccination there are bound to be a few casualties." Parents were entitled to weigh for themselves the risks of protecting their daughters by HPV vaccination, he said, "but there are also other methods, such as better screening". The latter comment was particularly inept, since regular screening will continue for many years and is in no sense an alternative to immunisation.
In its article on 1 October, The Guardian pointed out that vaccination programmes had not been suspended (there had simply been a slight delay in certain areas receiving vaccine supplies), and that a "serious underlying medical condition" was probably responsible for Natalie Morton's death. Next day, nearly all newspapers and radio and TV channels carried the pathologist's finding of a "large malignant tumour of unknown origin in the heart and lungs".
The immediate furore -though probably not underlying public anxiety -was at an end.
Bernard Dixon is the European editor of the American Association for Microbiology.
After considerable public and parliamentary debate in the UK that backed the creation of human-animal hybrid embryonic stem cells for research purposes, given the shortage of human-derived cells, research involving them currently appears to have been refused funding.
All three projects to develop embryonic stem cells from cloned embryos created by fusing human cells with animal cells have been stalled, after publicly-funded research councils refused to fund research involving the hybrid cells in this year's grant applications.
Two of the projects failed to win funds earlier this year and the third is now understood to have ended when a funding application was withdrawn after the research licence issued by the Human Fertilisation and Embryology Authority (HFEA), responsible for such research, expired during the summer without being renewed, The Independent newspaper reported.
Plans to allow British scientists to create human-animal embryos were approved in 2007 by the HFEA after it published its lengthy public consultation document. It found that the majority of people were 'at ease' with scientists creating the hybrid embryos.
The new Human Fertilisation and Embryology Act, which came into force last month, was specifically amended to permit the creation of cloned Britain's support for human-animal stem cell research seems to be faltering. Nigel Williams reports.
Stemmed cells
Challenge: The UK's support for embryonic stem cell research appears to be changing. (Picture: R. Yorgos Nikas/Science Photo Library.) embryos with nuclei from human cells inserted into the eggs of either cows, pigs, sheep or other animals.
When the issue was debated in Parliament, many leading scientists strongly supported such research.
"Animal-human hybrid embryo research needs legal permission, good scientists and more funding," says Evan Harris, the science spokesman for the Liberal Democrat Party. Many of those involved in campaigning for human-animal embryo research to be legal during the passage of the Human Fertilisation and Embryology Bill always knew that this was a controversial area of research. "But we also knew it was a field of enquiry which was necessary to keep open if those suffering from serious degenerative disorders were to be confident that all potential avenues for increasing knowledge about their condition, and indeed for funding possible treatments or even cures, were to be kept open," he wrote in The Independent.
"It is disappointing -at least on one level -that a year after the bill became law, none of the three teams that had a licence granted to conduct hybrid embryo research has received funding from the research councils to do the work."
But he believes the funding issue is not a boycott of the research. "The chief executive of the Medical Research Council has assured me that funding refusal of these applications was in no way a moral judgement on the work and was due solely to the imbalance between money available and the bids for it," he says. But "the question remains, however, that if we are to save human eggs for fertility treatment, then we have to find efficient ways of using animal eggs (with their nuclear material removed) as a substitute for the use of precious human eggs when making cloned embryos for research purposes in the lab."
While some researchers in the field are moving to other countries that are perceived to have a more favourable climate for embryonic stem cell research, Harris believes the UK will remain at the forefront. "Thanks to the HFE bill and the scientists who spent their time arguing their case to the politicians, the UK will remain a leading player in this work in the years to come, as long as the funding to bioscience is maintained." Honey bee populations in the US and in several European countries continue to suffer devastating losses, while the only firm scientific knowledge about the underlying causes so far is that they are multifactorial and include virus infections and environmental stress.
The Co-operative Group, a group of companies in the UK that is owned by its membership and takes pride in its ethical conduct of business, has now started an awareness campaign which includes the launch of a documentary film and the propagation of a 10-point plan designed to enable everybody to take part in helping bee colonies to survive.
The documentary Vanishing of the bees had its premiere at London and will be shown in independent cinemas across the UK during October and November (http:// vanishingbees.co.uk/screenings/). It highlights both the threat to crops depending on bee pollination and the need for more research to understand the causes of the problem.
Martin Smith, the Chairman of the British Beekeepers Association (BBKA), said: "The film Vanishing of the bees calls for increased research into the possible sub-lethal effects of neonicotinoid pesticides on honey bees. In February this year, the BBKA called for work to be done on this area to try to establish if there is a link with the decline in bee numbers in the UK, when it published its Research Concept document."
Neonicotinoid pesticides, such as clothianidin, affect the central nervous system of insects but are relatively harmless for mammals. They have been linked to a localised die-off of bees in Germany (Curr. Biol. 18, R684) and have been restricted in France, but they are still widely used in the UK.
As part of its 10-point 'Plan Bee', the Co-operative Group, which is also the UK's largest farmer, has pledged to stop the use of neonicotinoids on its own farms and in all own-brand fresh produce sold in its food stores. It has also made a research grant of £150,000 available for studies into possible causes of the colony losses.
Other points included in Plan Bee aim at raising awareness and involving the company's membership and customer base in grass-root measures to create a bee-friendly environment.
Michael Gross is a science writer based at Oxford. He can be contacted via his web page at www.michaelgross.co.uk
The Co-operative Group of businesses in the UK has backed a film and a 10-point plan to raise awareness of the continuing losses of vital bee colonies. Michael Gross reports.
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Chronic: The collapse in honey bee numbers is causing mounting concern. (Photo: Matthew Heinrichs/Alamy.)
